Curaleaf Holdings Inc.(CURA.TO)— 同業公司組

數據截至2026-09-18 — 評分每個交易日晚間重新計算。分組標準=首先為共同的Closelook指數成分,其次為產業。Closelook研究日記,不構成投資建議。

Curaleaf Holdings Inc.的Closelook綜合評分為31/100,在同業公司組內排名第12位(共12家)——組內評分最高的是BB Biotech AG(74/100)。

名稱綜合動能品質估值訊號距52週高點
CURA.TO Curaleaf Holdings Inc.31652226
ROVI.MC Laboratorios Farmaceuticos ROVI60207651info32.3%
LNTH Lantheus Holdings Inc60697558info10.1%
KNSA Kiniksa Pharmaceuticals Ltd56925819ok6.9%
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock54895742ok2.9%
BHC.TO Bausch Health Companies Inc54507083info28.5%
ALKS Alkermes Plc53665222info22.1%
APTX.TO Apotex Health Corp48595648
BION.SW BB Biotech AG74749681info8.2%
DXCM DexCom Inc66868035bull5%
ARGX.BR Argen-X65797528ok5.8%
ARGX argenx NV ADR64797427ok7.7%

評分為Closelook全部涵蓋範圍內的相對讀數——方法論詳見公司評分說明。訊號燈來自每日夜間訊號看板

FAQ · from the current data · as of 2026-09-18

Quick answers

Curaleaf Holdings Inc.在Closelook涵蓋範圍內的同業公司有哪些?

分組首先根據共同的Closelook指數成分,其次根據產業:Laboratorios Farmaceuticos ROVI (ROVI.MC)、Lantheus Holdings Inc (LNTH)、Kiniksa Pharmaceuticals Ltd (KNSA)、Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX)、Bausch Health Companies Inc (BHC.TO)、Alkermes Plc (ALKS)、Apotex Health Corp (APTX.TO)、BB Biotech AG (BION.SW)等。

CURA.TO相對同業公司的評分如何?

Curaleaf Holdings Inc.的綜合評分為31/100,組內排名第12位(共12家),截至2026-09-18;組內最高綜合評分為BB Biotech AG(74/100)。Closelook評分為研究日記讀數,不構成評等或投資建議。

Related in the Closelook universe

then Drug Manufacturers - Specialty & Generic, then Healthcare. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.